The skin is a common target organ of adverse drug reactions.
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The pharrnacokinetics of indomethacip (I) was assessed in infants who received prophylactic ( . I ) for patent ductus arteriosus (FDA). The first dose (0.2 mglkg), given within 12 hours after birth, was followed by two q 12 hourly doses (0.1 rnglkg). The mean birth weight (BW) of these infants was 923 2 134.0 gm (range:730-1070gm) with a mean gestational age of 28.1 2 2 wks (range:31-25 wks). None of the infants subsequently developed a significant PDA. Plasma (I) levels were measured by high performance liquid chromatography at 1, 13, 36, 72, 96, 168 373.4+197 The mean plasma t 112 of (I) in these infants (71.3+39.1 h;s) was significantly prolonged when compared with previously reported values. Furthermore the mean plasma t 112 of (I) was significantly longer in the <lo00 gm infants (p<0.05). While the minimum efficacious dose for prophylactic (I) has not been established, all but one infant had a level > .250pg 7 days following (I).
These data strongly suggest that previously recommended dosages of (I) for very low birth weight infants in the first 48 hrs. may result in very elevated and prolonged levels.
PHARMACOKINETICS OF NALOXONE IN PREMATURE INFANTS.
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Raoid d i s i
o o e e r a n c e o f n a l o x o n i was observed i n a arouo o f very l o w b i r t h w e i g h t i n f a n t s examined f o r naloxone k i n e i i c s . F i v e i n f a n t s (BW 1 .20+0.25kg, GA 292lwk) r e c e i v e d 0.04 mg/per kg o f naloxone i n t r a v e n o u s l y , f o u r w i t h i n t h e f i r s t week o f l i f e and one on day 26. S e r i a l serum samples were o b t a i n e d a t spec i f i c time i n t e r v a l s and frozen f o r subsequent a n a l y s i s . Serum naloxone c o n c e n t r a t i o n s were measured by t h e radioimmunoassay method o f Berkowi t z (1 975).
S e r i a l naloxone c o n c e n t r a t i o n a t 5 min. was 51.5+13.4pmole/ ml, a t 15 min. 36.7+4.0pmole/ml, a t 30 min. 28.9+5.lpmole/ml, a t 60 min. 20.4+5.9pmole/ml, a t 120 m i n . 7.3+2.4pmole/ml, and 240 min. 1 .5+0.4pmole/ml.
No naloxone was d e t e c t e d a t t h e n e x t sample t i m e ( 1 2 h r s ) . The e l i m i n a t i o n r a t e c o n s t a n t (Ke) c a l c ul a t e d from t h e decay p o r t i o n o f t h e e l i m i n a t i o n curve was 0.8231 0.130/hr.
The c a l c u l a t e d h a l f l i f e ( t k ) was 51.829.2min. No c o r r e l a t i o n s were found between Ke and t 4 and i n i t i a l serum l e v e l , b i r t h w e i g h t , g e s t a t i o n a l age, and p o s t n a t a l age. This group o f i n f a n t s demonstrated r a p i d e l i m i n a t i o n o f i ntravenous naloxone, c o n s i s t e n t w i t h r e s u l t s o b t a i n e d i n a d u l t s . Approximately 3% of the adult population have a genetic basis for decreased PChE enzyme activity. Levels of PChE activity in healthy term newborns and infants up to 4 months of age have been reported to range from 22-86% of normal adult values. The degree of decreased enzyme activity in premature infants is unknown. Levels of PChE were measured in 39 healthy premature infants (single determinations in 12 and serial weekly determinations in 27).Blrth weight ranged from 1430-2070g and GA ranged from 28-37 wks. Ten adult donor and 20 term newborn blood samples were analyzed for comparison purposes. Levels of PChE were measured in duplicate by a kit dye reduction method(norma1 adult reference value 7-19Ulml). Abnormally low PChE levels were found in 10% of adult, 15% of term newborn and 20% of premature infant blood samples(NS). This incidence of low PChE activity is 3-5 times that reported for adults using a different method. In 6 premature infants with initially low PChE levels, the enzyme activity rose to normal adult range within 2 weeks. In 2 other premature infants PChE levels remained low and most likely represented congenital PChE deficiency. There was no difference in PChE activity on the basis of sex, race or CA. Hospitalized premature infants exhibit similar rates of quantitative PChE deficiency when compared to adults and term infants and are at potential risk for significant complications when exposed to depolarizing muscle relaxant agents. When succinylcholine use is considered in premature infants, measurement of PChE levels or use of alternative drugs may be indicated on the basis of transient PChE deficiency.
ANIMAL MODEL OF BENZOCAINE INDUCED METHEMOGLOBINEMIA
394 Philip L. Tomes, University of Massachusetts Med.
Center, Department of Pediatrics, TJorcester. Methemoglobinemia has been reported in a small number of infants after topical application of benzocaine. Since it is a widely used medication, these rare occurrences have been considered to possibly represent idiosyncratic response. Varying amounts of benzocaine (1.5,3,6,12.5,25,50,100 mg) were administered by stomach tube, in a single 1.0 ml bolus, to 117 young (approx. 175 gm) Charles River CD male rats. Animals were sacrificed after 30 or 60 minutes and methemoglobin levels determined spectrophotometrically. Methemoglobin levels were negligible at the lowest dose of benzocaine (1.5 mg), but significant levels (20 -70% of total hemoglobin) were found at the other dose levels. Pretreatment of animals with ascorbate (30 -60 minutes before administering benzocaine) or simultaneous administration of varying amounts of ascorbate (up to 100 mg) failed to provide a protective effec,t during the p riod of observation (60 minutes) in animals receiving 3 or 6 mg bszocaine. Renzocaine does not induce methemoglobin formation in either incubated washed red cells or solutions of hemoglobin. Thus,the rapid formation of methemoglobin in intact animals suggests that the oxidant effect is caused by a metabolite of benzocaine. Washed red cells incubated in mixtures containing liver microsomes, benzocaine, and either NADH or NADPH were found to readily form methemoglobin, confirming notion that the oxidant is a biotransformation product of benzocaine. The relative rarity of benzocaine induced methemoglobinemia may be explained by overdosage rather than idiosyncratic response. and Phvsioloav. U n i v e r s i t v o f Colorado School o f Medicine. Denver. ~i s t a m i n e -" ( H ) i s known"to d i l a t e t h e f e t a l pulmonary c i r c u l at i o n . The r e c e p t o r c h a r a c t e r i s t i c s , however, have n o t been comp l e t e l y described. To do so, we determined dose response curves (DRC) t o H and t o H w i t h i n f u s i o n o f H1 and/or HZ a n t a g o n i s t s i n 6 c h r o n i c a l l y prepared f e t a l sheep. A c u f f e l e c t r o m a g n e t i c flow probe measured b l o o d f l o w t o t h e l e f t l u n g ( Q L ) . Catheters i n t h e main pulmonary a r t e r y and a o r t a measured pressure. A l e f t pulmonary a r t e r y (LPA) c a t h e t e r a l l o w e d l o c a l i n f u s i o n o f H thereby m i n i m i z i n g systemic e f f e c t s . QL i n c r e a s e d l o g a r i t h m i c a ll y from H doses o f 112 ng.kg-1 t o 16 ng.kg-1.
A t H = 16 n g . k g -l , QL was 110% o v e r b a s e l i n e . The DRC plateaued a t l a r g e r H doses. A l l H doses up t o 125 ng.kg-1 had no e f f e c t on systemic o r pulmon a r y p r e s s u r e o r on h e a r t r a t e . Diphenhydramine (D), an H1 ant a g o n i s t , g i v e n s y s t e m i c a l l y , s h i f t e d t h e DRC t o t h e r i g h t w i t h a dose r a t i o o f 26. C i m e t i d i n e (C), an HZ a n t a g o n i s t , had a s i m il a r e f f e c t w i t h a dose r a t i o o f 1.5.
Simultaneous 0 and C r es u l t e d i n a dose r a t i o o f 55. H1 and HZ r e c e p t o r s were f u r t h e r confirmed by t h e use o f s p e c i f i c H1 ( 2 -p y r i d y l e t h y l a m i n e ) and H2 ( D i m e p r i t ) a g o n i s t s . We conclude t h a t t h e marked s e n s i t i v i t y o f t h e f e t a l pulmonary c i r c u l a t i o n t o H i s mediated t h r o u g h b o t h H1 and H2 r e c e p t o r s . These f i n d i n g s c o n t r a s t w i t h those o f p r e v i o u s s t u d i e s i n t h e hypoxic a d u l t pulmonary c i r c u l a t i o n where a t y p i c a l H2 r e c e p t o r s may be p r e s e n t , b u t agree w i t h f i n d i n g s i n t h e hyo o x i c newborn lamb.
